| Population pharmacokinetic–pharmacodynamic modelling in oncology: a tool for predicting clinical response BC Bender, E Schindler, LE Friberg British journal of clinical pharmacology 79 (1), 56-71, 2015 | 99 | 2015 |
| A pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patients E Panoilia, E Schindler, E Samantas, G Aravantinos, HP Kalofonos, ... Cancer chemotherapy and pharmacology 75 (4), 791-803, 2015 | 59 | 2015 |
| A Minimal Continuous-Time Markov Pharmacometric Model E Schindler, MO Karlsson The AAPS journal 19 (5), 1424-1435, 2017 | 27 | 2017 |
| PK‐PD modeling of individual lesion FDG‐PET response to predict overall survival in patients with sunitinib‐treated gastrointestinal stromal tumor E Schindler, MA Amantea, MO Karlsson, LE Friberg CPT: Pharmacometrics & Systems Pharmacology 5 (4), 173-181, 2016 | 19 | 2016 |
| A Pharmacometric Analysis of Patient-Reported Outcomes in Breast Cancer Patients Through Item Response Theory E Schindler, LE Friberg, BL Lum, B Wang, A Quartino, C Li, S Girish, ... Pharmaceutical research 35 (6), 122, 2018 | 17 | 2018 |
| A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients E Schindler, MA Amantea, MO Karlsson, LE Friberg CPT: pharmacometrics & systems pharmacology 6 (6), 373-382, 2017 | 17 | 2017 |
| Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib‐Treated Patients With Gastrointestinal Stromal Tumors E Schindler, SM Krishnan, RHJ Mathijssen, A Ruggiero, G Schiavon, ... CPT: pharmacometrics & systems pharmacology 6 (7), 449-457, 2017 | 13 | 2017 |
| Pharmacometric analysis of the relationship between absolute lymphocyte count, and expanded disability status scale and relapse rate, efficacy endpoints, in multiple sclerosis … AM Novakovic, A Thorsted, E Schindler, S Jönsson, A Munafo, ... | 9 | 2017 |
| PKPD-modeling of Standard Uptake Value (SUV) in Gastro-Intestinal Stromal Tumors (GIST) patients treated with sunitinib E Schindler, P Westwood, M Amantea, EK Hansson, PA Milligan, ... Annual Meeting of the Population Approach Group in Europe (PAGE), 2012 | 2 | 2012 |
| Pharmacometrics to improve clinical benefit assessment in oncology E Schindler Acta Universitatis Upsaliensis, 2018 | 1 | 2018 |
| Analyzing Patient-Reported Outcomes in Breast Cancer through Item-Response Theory Pharmacometric Modeling E Schindler, B Wang, B Lum, S Girish, JY Jin, LE Friberg, MO Karlsson Abstracts for American conference on pharmacometrics 2015, 2015 | 1 | 2015 |
| II-43 Eirini Panoilia A population PK model for bevacizumab when combined with chemotherapy in patients with metastatic colorectal cancer stage IV E Panoilia, E Schindler, A Brekkan, B Bender, E Samantas, G Aravantinos, ... | | |
| II-07 Emilie Schindler PKPD-Modeling of Standard Uptake Value (SUV) in Gastro-Intestinal Stromal Tumors (GIST) patients treated with sunitinib E Schindler, P Westwood, M Amantea, EK Hansson, PA Milligan, ... | | |
